Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,704 public trials 1,045 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer

NCT02613507

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Local Institution - 0051 Beijing, Beijing Municipality, China
  • Local Institution - 0007 Beijing, Beijing Municipality, China
  • Local Institution - 0032 Beijing, Beijing Municipality, China
  • Local Institution - 0026 Beijing, Beijing Municipality, China
View all 33 locations
View Trial Details
Completed

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

NCT05712889

Conditions
Adnexal Diseases, Biliary Tract Diseases, Biliary Tract Neoplasms, +43 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • NEXT Austin Austin, Texas, United States
  • NEXT Oncology San Antonio San Antonio, Texas, United States
  • Macquarie University Macquarie Park, New South Wales, Australia
View Trial Details
Completed

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

NCT02635672

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +65 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Maryland Oncology Hematology Silver Spring, Maryland, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
View all 16 locations
View Trial Details
Completed

A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations

NCT02113813

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Site US10010 Washington D.C., District of Columbia, United States
  • Site US10006 Baltimore, Maryland, United States
  • Site US10012 Boston, Massachusetts, United States
  • Site US10001 Boston, Massachusetts, United States
View Trial Details
Completed

TEIPP Immunotherapy in Patients With NSCLC

NCT05898763

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Leiden University Medical Center Leiden, South Holland, Netherlands
  • Erasmus Medical Center Rotterdam, South Holland, Netherlands
View Trial Details
Completed

Phase II AZD9291 Open Label Study in NSCLC After Previous EGFR TKI Therapy in EGFR and T790M Mutation Positive Tumours

NCT02094261

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Orange, California, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Norwalk, Connecticut, United States
View all 44 locations
View Trial Details
Completed

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

NCT04504669

Conditions
Adenocarcinoma, Advanced Solid Tumours, Breast Diseases, +48 more
Locations
  • Research Site Baltimore, Maryland, United States
  • Research Site St Louis, Missouri, United States
  • Research Site Huntersville, North Carolina, United States
  • Research Site Franklin, Tennessee, United States
View all 13 locations
View Trial Details

Related conditions